Company:  PERSONALIS, INC. (PSNL)
Form Type:  S-1MEF
Filing Date:  6/19/2019 
CIK:  0001527753 
Address:  1330 O'BRIEN DRIVE 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650-752-1300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.88  
Change: 
-0.02 (-0.23%)  
Trade Time: 
Nov 20  
Market Cap: 
$277.36M
Trade PSNL now with

© 2019  
Description of Business
We are a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient's cancer and immune response. We designed our NeXT Platform to adapt to the complex and evolving understanding of cancer, providing our biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover roughly 50 to 500 genes. We are also developing a complementary liquid biopsy assay that analyzes all human genes versus the more narrowly focused liquid biopsy assays that are currently available. By combining technological innovation, operational scale, and regulatory differentiation, our NeXT Platform is designed to help our customers obtain new insights into the mechanisms of response and resistance to therapy as well as new potential therapeutic targets.
Register and access this filing in:     
  FORM S-1MEF
    CALCULATION OF REGISTRATION FEE
    EXPLANATORY NOTE AND
    EXHIBIT INDEX
    SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM